Gone but not Forgotten: Discontinued Obesity Medications
Like other medication classes, anti-obesity medications (AOMs) have seen their fair share of pharmacotherapy withdrawal from the market. Reasons range…
Archives: Content
Knowledge Check: Growth Deficiency, RIP Meds, Endoscopy, and MI
Knowledge checks will be available every fifth blog and consist of a checklist of objectives and questions based on the prior blog posts. In addition,…
Black Box Warning: Medullary Thyroid Carcinoma
A boxed warning, more commonly referred to as a “black box warning” due to the thick black border surrounding the text, is the strongest safety wa…
Part 2: AACE Algorithm for Evaluation and Treatment of Obesity
This is the second part of our two-part blog series covering The American Association of Clinical Endocrinology Consensus Statement: Algorithm for the…
Part 1: AACE Algorithm for Evaluation and Treatment of Obesity
The American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Ba…
Air Displacement Plethysmography: Principles, Benefits, & Limits
Although dual-energy X-ray absorptiometry is considered the gold standard for body composition assessment, air displacement plethysmography (ADP) is a…
Knowledge Check: Flexible FDA, POMC, Tirzepatide, Built Setting
Knowledge checks will be available every fifth blog and consist of a checklist of objectives and questions based on the prior blog posts. In addition,…
SURPASS to SURMOUNT: The Tirzepatide Trials To Know
In 2022, when I first started writing ABOM study blogs, one of my earliest posts focused on tirzepatide. The then–hot-off-the-press SURMOUNT-1 trial…
Built Environment and Obesity: Density, Walkability, Pollution
One of the topics now included in the updated ABOM test content outline is the built environment (A.8), specifically the relationship between the buil…
Red Hair, Pale Skin, and Adrenal Crisis: POMC Deficiency
Proopiomelanocortin (POMC) deficiency is a relatively recently defined condition, first described in 1998. It is also very rare, affecting fewer than …
Flexibility in Pharmacotherapy: Updated FDA-Indications
Over the past year, indications for anti-obesity medications (AOM) have shifted from strict BMI cut-offs to broader, more inclusive criteria. In this …
Comprehensive Guide for Mastering the ABOM Exam in 2026
The ABOM examination is a great way to gain knowledge and confidence in treating those with obesity, but often, it can be overwhelming to know where t…
Now Available: The 2026 Obesity Medicine Review Package
With the 2025 ABOM testing season wrapped up, many prospective candidates are gearing up for the 2026 ABOM exam and looking for the best study resourc…
I took the Exam…. NOW WHAT?? Carolynn Francavilla, MD, FOMA, ABOM
One of the challenges I see for physicians who take the ABOM exam is what to do next. And I get it! Very few of us had the opportunity to actually see…
Trick or Treat: Last Minute Study Test Tips (Updated 2025)
The ABOM testing window is quickly approaching! You may feel overwhelmed with so much information to cover and so little time left. Studying for this …
